Managing headache during pregnancy and lactation

Expert Review of Neurotherapeutics

Volumn 8, Issue 3, 2008, Pages 385-395

  Marcus, Dawn A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Breastfeeding; Migraine; Nursing; Tension type; Trimester

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; AMITRIPTYLINE; ANALGESIC AGENT; ANTIEMETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTORPHANOL; ERGOTAMINE; ESTROGEN; GABAPENTIN; IBUPROFEN; LAMOTRIGINE; NAPROXEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PAROXETINE; PROCHLORPERAZINE; PROMETHAZINE; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TIMOLOL; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VERAPAMIL;

AEROBIC EXERCISE; AGITATION; BREAST FEEDING; BREAST FEEDING EDUCATION; CEREBROSPINAL FLUID EXAMINATION; CHRONIC PAIN; CONTRACEPTION; DIAGNOSTIC TEST; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE DURATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ESTROGEN BLOOD LEVEL; FEEDBACK SYSTEM; FETUS DISEASE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HEADACHE; HUMAN; IRRITABILITY; LACTATION; LIFESTYLE MODIFICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MATERNAL HYPERTENSION; MATERNAL NUTRITION; MIGRAINE; NERVOUSNESS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL CRYING; PHLEBOGRAPHY; PHYSIOTHERAPY; PREGNANCY; PREGNANCY OUTCOME; PRIMARY HEADACHE; RELAXATION TRAINING; RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; SECONDARY HEADACHE; SIDE EFFECT; SLEEP DISORDER; SMOKING CESSATION; STRESS MANAGEMENT; THIRD TRIMESTER PREGNANCY; TREMOR; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

ANALGESICS; BREAST FEEDING; COMBINED MODALITY THERAPY; FEMALE; HEADACHE; HUMANS; MIGRAINE DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 41749088431     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.3.385     Document Type: Review

References (75)

1. Callaghan N. The migraine syndrome in pregnancy. Neurology 18, 197-199 (1968).
2. Granella F, Sances G, Zanferrari C et al. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 33, 385-389 (1993).
3. Chen TC, Leviton A. Headache recurrences in pregnant women with migraine. Headache 34, 107-110 (1994).
4. Maggioni F, Alessi C, Maggino T et al. Primary headaches and pregnancy. Cephalalgia 15, 54 (1995).
5. Melhado EM, Maciel JA, Guerreiro CM. Headache during gestation: evaluation of 1101 women. Can. J. Neurol. Sci. 34, 187-192 (2007).
6. Marcus DA, Scharff L, Turk DC. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 39, 625-632 (1999).
7. Sances G, Granella F, Nappi RE et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 23, 197-205 (2003). • Prospective study documenting migraine changes with pregnancy.
8. Facchinetti F, Allais G, D'Amico R, Benedetto C, Volpe A. The relationship between headache and preeclampsia: a case-control study. Eur. J. Obstet. Gynecol. Reprod. Biol. 121, 143-148 (2005).
9. Kurth T. Associations between migraine and cardiovascular disease. Expert Rev. Neurotherapeutics 7(9), 1097-1104 (2007).
10. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet. Gynecol. 106, 509-516 (2005).
11. Coad J, Al-Rasasi B, Morgan J. Nutrient insult in early pregnancy. Proc. Nutr. Soc. 61, 51-59 (2002).
12. Wainscott G, Sullivan FM, Volans GN, Wilkinson M. The outcome of pregnancy in women suffering from migraine. Postgrad. Med. J. 54, 98-102 (1978).
13. O'Quinn S, Ephross SA, Williams V et al. Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch. Gynecol. Obstet. 263, 7-12 (1999).
14. Bànhidy F, Acs N, Horváth-Puhó E, Czeizel AE. Pregnancy complications and delivery outcomes in pregnant women with severe migraine. Eur. J. Obstet. Gynecol. Reprod. Biol. 134, 157-163 (2007).
15. Bànhidy F, Acs N, Horváth-Puhó E, Czeizel AE. Maternal severe migraine and risk of congenital limb deficiencies. Birth Defects Res. Part A Clin. Mol. Teratol. 76, 592-601 (2006).
16. Wall VR. Breastfeeding and migraine headaches. J. Hum. Lact. 8, 209-212 (1992).
17. Marcus DA. Headache in pregnancy. Curr. Pain Headache Rep. 7, 288-296 (2003).
18. Francois P, Fabre M, Lioret E, Jan M. Vascular cerebral thrombosis during pregnancy and post-partum. Neurochirurgie 46, 105-109 (2000).
19. Lanska DJ, Kryscio RJ. Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology 51, 1622-1628 (1998).
20. Panagariya A, Maru A. Cerebral venous thrombosis in pregnancy and puerperium - a prospective study. J. Assoc. Physicians India 45, 857-859 (1997).
21. Azpilcueta A, Peral C, Giraldo I, Chen FJ, Contreras G. Meningioma in pregnancy. Report of a case and review of the literature. Ginecol. Obstet. Mex. 63, 349-351 (1995).
22. Saitoh Y, Oku Y, Izumoto S, Go J. Rapid growth of a meningioma during pregnancy: relationship with estrogen and progesterone receptors - case report. Neurol. Med. Chir. (Tokyo) 29, 440-443 (1989).
23. Arseni C, Simoca I, Jipescu I, Leventi E, Grecu P, Sima A. Pseudotumor cerebri: risk factors, clinical course, prognostic criteria. Rom. J. Neurol. Psychiatry 30, 115-132 (1992).
24. Katz VL, Peterson R, Cefalo RC. Pseudotumor cerebri and pregnancy. Am. J. Perinatol. 6, 442-445 (1989).
25. Koontz WL, Herbert WP, Cefalo RC. Pseudotumor cerebri in pregnancy. Obstet. Gynecol. 62, 324-327 (1983).
26. Ertresvg JM, Stovner LJ, Kvavik LE et al. Migraine aura or transient ischemic attacks? A five-year follow-up case-controlled study of women with transient central nervous system disorders in pregnancy. BMC Med. 5, 19 (2007).
27. Davis LE. Normal laboratory values of CSF during pregnancy. Arch. Neurol. 36(7), 443 (1979).
28. Sandrini G, Friberg L, Jänig W et al. Neurophysiological tests and neuroimaging procedures in non-acute headache: guidelines and recommendations. Eur. J. Neurol. 11, 217-224 (2004).
29. Marcus DA. Central nervous system abnormalities in migraine. Expert Opin. Pharmacother. 4, 1709-1715 (2003).
30. Ramchandren S, Cross BJ, Liebeskind DS. Emergent headaches during pregnancy: correlation between neurologic examination and neuroimaging. Am. J. Neuroradiol. 28, 1085-1087 (2007).
31. Levine D, Barnes PD, Edleman RR. Obstetric MR imaging. Radiology 211, 609-617 (1999).
32. Baker P, Johnson I, Harvey P, Mansfield P. A three-year follow-up of children imaged in utero using echo-planar magnetic resonance. Am. J. Obstet. Gynecol. 170, 32-33 (1994).
33. Kanal E, Gillen J, Evans J, Savitz D, Shellock F. Survey of reproductive health among female MR workers. Radiology 187, 395-399 (1993).
34. Garcia-Bournissen F, Shrim A, Koren G. Safety of gadolinium during pregnancy. Can. Fam. Physician 52, 309-310 (2006).
35. Webb JW, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur. Radiol. 15, 1234-1240 (2005).
36. Gomes KR, Moron AF, Silva R, Siqueira AA. Prevalence of use of medicines during pregnancy and its relationship to maternal factors. Rev. Saude Publica 33, 246-254 (1999).
37. Damase-Michel C, Lapeyre-Mestre M, Moly C, Fournie A, Montastruc JL. Drug use during pregnancy: survey in 250 women consulting at a university hospital center. J. Gynecol. Obstet. Biol. Repro. (Paris) 29, 77-85 (2000).
38. Fonseca MR, Fonseca E, Bergsten-Mendes G. Prevalence of drug use during pregnancy: a pharmacoepidemiological approach. Rev. Saude Publica 36, 205-212 (2002).
39. Marcus DA, Scharff L, Turk DC. Nonpharmacologial management of headaches during pregnancy. Psychosom. Med. 57, 527-535 (1995).
40. Scharff L, Marcus DA, Turk DC. Maintenance of effects in the nonmedical treatment of headaches during pregnancy. Headache 36, 285-290 (1996).
41. Medina JL, Diamond S. The role of diet in migraine. Headache 18, 31-34 (1978).
42. Mosek A, Korczyn AD. Yom Kippur headache. Neurology 45, 1953-1955 (1995).
43. Topacoglu H, Karcioglu O, Yuruktumen A et al. Impact of Ramadan on demographics and frequencies of disease-related visits in the emergency department. Int. J. Clin. Pract. 59, 900-905 (2005).
44. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 45, 904-910 (2005). • A large study documenting the relationship of sleep disturbance to migraine activity.
45. Hedman C, Pohjasvaara T, Tolonen U, Suhonen-Malm AS, Myllylä VV. Effects of pregnancy on mothers' sleep. Sleep Med. 3, 37-42 (2002).
46. Christian P, West KP, Katz J et al. Cigarette smoking during pregnancy in rural Nepal. Risk factors and effects of β-carotene and vitamin A supplementation. Eur. J. Clin. Nutr. 58, 204-211 (2004).
47. Kohlenberg RT, Cahn T. Self-help treatment for migraine headaches: a controlled outcome study. Headache 21, 196-200 (1981).
48. Cordingley G, Holrody K, Pingel J, Jerome A, Nash J. Amitriptyline versus stress management therapy in the prophylaxis of chronic tension headache. Headache 30, 300 (1990).
49. Marcus DA, Scharff L, Mercer S, Turk DC. Nonpharmacological treatment for migraine: incremental utility of physical therapy with relaxation and thermal biofeedback. Cephalalgia 18, 266-272 (1998).
50. Köseoglu E, Akboyraz A, Soyuer A, Ersoy AÖ. Aerobic exercise and plasma β endorphin levels in patients with migrainous headache without aura. Cephalalgia 23, 972-976 (2003).
51. American Academy of Pediatric Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 108, 776-789 (2001).
52. Kallen B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 41, 351-356 (2001).
53. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. Br. Med. J. 327(7411), 368 (2003).
54. Evers S, Áfra J, Frese A et al. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur. J. Neurol. 13, 560-572 (2006).
55. Bracken MB, Holfod TR. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet. Gynecol. 58, 336-344 (1981).
56. Saxén I. Epidemiology of cleft lip and palate. An attempt to rule out chance correlations. Br. J. Prev. Soc. Med. 29, 103-110 (1975).
57. Saxén I. Associations between oral clefts and drugs taken during pregnancy. Int. J. Epidemiol. 4(1), 37-44 (1975).
58. Beers MH, Berkow R. Drug use and dependence. In: The Merck Manual of Diagnostics and Therapeutics (17th Edition). Beers MH, Berkow R (Eds). John Wiley & Sons, NJ, USA (1999).
59. Luty J, Nikolaou V, Bearn J. Is opiate detoxification unsafe in pregnancy? J. Subst. Abuse Treat. 24, 363-367 (2003).
60. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Ann. Emerg. Med. 14, 262-264 (1996).
61. Hemels ME, Einarson A, Koren G, Lanctot KL, Einarson TR. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann. Pharmacother. 39, 803-809 (2005). • The safety of antidepressants during pregnancy was evaluated in this large metaanalysis that included data from more than 3500 women.
62. Goodman JF. Treatment of headache with bupropion. Headache 37, 256 (1997).
63. Pinsker W. Potentially safe and effective new treatment for migraine? Headache 38, 58 (1998).
64. No authors listed. Bupropion (amfebutaone): caution during pregnancy. Prescrire Int. 14, 225 (2005).
65. Chun-Fai-Chan B, Koren G, Fayez I et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am. J. Obstet. Gynecol. 192, 932-936 (2005).
66. Mathew NT, Rapoport A, Saper J et al. Efficacy of gabapentin in migraine prophylaxis. Headache 41, 119-128 (2001).
67. Montouris G. Gabapentin exposure in human pregnancy: results from the Gabpentin Pregnancy Registry. Epilepsy Behav. 4, 310-317 (2003).
68. Moses-Kolko EL, Bogen D, Perel J et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293, 2372-2383 (2005).
69. Göbel H, Schmidt G, Soyka D. Effect of peppermint and eucalyptus oil preparations on neurphysiological and experimental algesimetric headache parameters. Cephalalgia 14, 228-234 (1994).
70. Göbel H, Fresenius J, Heinze A, Dworschak M, Soyka D. Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension type. Nervenarzt 67, 672-681 (1996).
71. Kliger B, Chaudhary S. Peppermint oil. Am. Fam. Physician 75, 1027-1030 (2007).
72. Blumenthal M. The ABC Clinical Guide to Herbs. Blumenthal M, Brinckmann J, Wollschlaeger B (Eds). Thieme Medical Publishers Inc., NY, USA (2003).
73. th September 2007). www.acr.org
74. Reprotox®. An information system on environmental hazards to human reproduction and development. www.reprotox.org
75. Health Statistics: age of women at first childbirth (most recent) by country. (Accessed 30th September 2007). www.nationmaster.com/graph/hea_age_of_ wom_at_fir_chi-health-age-women-firstchildbirth